105 related articles for article (PubMed ID: 3802704)
1. Clinical pharmacology of carvedilol in normal volunteers.
Cubeddu LX; Fuenmayor N; Varin F; Villagra VG; Colindres RE; Powell JR
Clin Pharmacol Ther; 1987 Jan; 41(1):31-44. PubMed ID: 3802704
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of the vasodilatory effect of carvedilol in normal volunteers: a comparison with labetalol.
Cubeddu LX; Fuenmayor N; Varin F; Villagra VG; Colindres RE; Powell JR
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S81-4. PubMed ID: 2454374
[TBL] [Abstract][Full Text] [Related]
3. Vasodilating mechanism and response to physiological pressor stimuli of acute doses of carvedilol compared with labetalol, propranolol and hydralazine.
Tomlinson B; Bompart F; Graham BR; Liu JB; Prichard BN
Drugs; 1988; 36 Suppl 6():37-47. PubMed ID: 2908303
[TBL] [Abstract][Full Text] [Related]
4. Haemodynamics of carvedilol in normal subjects compared with propranolol, pindolol, and labetalol.
Tomlinson B; Cronin CJ; Graham BR; Prichard BN
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S69-75. PubMed ID: 2454372
[TBL] [Abstract][Full Text] [Related]
5. The dose dependency of the alpha- and beta-adrenoceptor antagonist activity of carvedilol in man.
Tham TC; Guy S; McDermott BJ; Shanks RG; Riddell JG
Br J Clin Pharmacol; 1995 Jul; 40(1):19-23. PubMed ID: 8527263
[TBL] [Abstract][Full Text] [Related]
6. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
Wong GW; Laugerotte A; Wright JM
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the mechanism underlying the vasodilator action of carvedilol in pithed spontaneously hypertensive rats.
Hashimoto H; Tanaka M; Kanda A; Akashi A
Drugs; 1988; 36 Suppl 6():31-6. PubMed ID: 2908302
[TBL] [Abstract][Full Text] [Related]
8. Alpha 1-blocking properties of carvedilol during acute and chronic administration.
Giannattasio C; Cattaneo BM; Seravalle G; Carugo S; Mangoni AA; Grassi G; Zanchetti A; Mancia G
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S18-22. PubMed ID: 1378144
[TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacology of carvedilol.
Tomlinson B; Prichard BN; Graham BR; Walden RJ
Clin Investig; 1992; 70 Suppl 1():S27-36. PubMed ID: 1350481
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic differences between carvedilol and labetalol in the cutaneous circulation.
Ruffolo RR; Sauermelch CF; Willette RN
Eur J Clin Pharmacol; 1990; 38 Suppl 2():S112-4. PubMed ID: 1974499
[TBL] [Abstract][Full Text] [Related]
11. The effect of losartan and carvedilol on vasopressor responses to adrenergic agonists and angiotensin II in the systemic circulation of Sprague Dawley rats.
Abdulla MH; Sattar MA; Abdullah NA; Khan MA; Anand Swarup KR; Johns EJ
Auton Autacoid Pharmacol; 2011; 31(1-2):13-20. PubMed ID: 21166975
[TBL] [Abstract][Full Text] [Related]
12. Local cutaneous hemodynamic effects of carvedilol and labetalol in the anesthetized rat.
Willette RN; Sauermelch CF; Ruffolo RR
Eur J Pharmacol; 1990 Feb; 176(2):237-40. PubMed ID: 2311669
[TBL] [Abstract][Full Text] [Related]
13. Features of the acute hypotensive action of carvedilol and its ameliorating effect on myocardial ischemia.
Hashimoto H; Kanda A; Hubo H; Tanaka M
J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S22-8. PubMed ID: 1721975
[TBL] [Abstract][Full Text] [Related]
14. The alpha- and beta-adrenoceptor blocking activities of labetalol and its RR-SR (50:50) stereoisomers.
Riva E; Mennini T; Latini R
Br J Pharmacol; 1991 Dec; 104(4):823-8. PubMed ID: 1687367
[TBL] [Abstract][Full Text] [Related]
15. Carvedilol increases blood pressure response to phenylephrine infusion in heart failure subjects with systolic dysfunction: evidence of improved vascular alpha1-adrenoreceptor signal transduction.
Van Tassell BW; Rondina MT; Huggins F; Gilbert EM; Munger MA
Am Heart J; 2008 Aug; 156(2):315-21. PubMed ID: 18657662
[TBL] [Abstract][Full Text] [Related]
16. Studies on the mode of vasodilating action of carvedilol.
Sponer G; Strein K; Müller-Beckmann B; Bartsch W
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S42-8. PubMed ID: 2454366
[TBL] [Abstract][Full Text] [Related]
17. The relationships between the cardiovascular effects, alpha- and beta-adrenoceptor blocking actions and plasma concentration of labetalol in doca hypertensive rats.
Drew GM; Hilditch A; Levy GP
Clin Exp Hypertens (1978); 1979; 1(5):597-611. PubMed ID: 42517
[TBL] [Abstract][Full Text] [Related]
18. Assessment of alpha- and beta-adrenoceptor blocking actions of labetalol.
Richards DA; Tuckman J; Prichard BN
Br J Clin Pharmacol; 1976 Oct; 3(5):849-55. PubMed ID: 9968
[TBL] [Abstract][Full Text] [Related]
19. Comparative effects of adimolol, labetalol and propranolol on heart rate and blood pressure in man.
Riddell JG; Harron DW; Shanks RG
Br J Clin Pharmacol; 1985 Apr; 19(4):405-10. PubMed ID: 2859871
[TBL] [Abstract][Full Text] [Related]
20. A pharmacokinetic study of carvedilol (BM 14.190) in elderly subjects: preliminary report.
Louis WJ; McNeil JJ; Workman BS; Drummer OH; Conway EL
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S89-93. PubMed ID: 2454376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
